Abiraterone

abiraterone · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

47 regulatory and trial events tracked for Abiraterone, covering 2015-06-22 to 2026-04-28. Get the full timeline:

Most recent: Clinical Trial Results: Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer [Phase 1]